We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA: Releasing More Trial Data Could Hasten Medtech Development
U.S. FDA: Releasing More Trial Data Could Hasten Medtech Development
July 2, 2013
The U.S. Food and Drug Administration is considering making available more masked and de-identified safety and efficacy data from clinical and preclinical trials to boost opportunities for innovative development of medical technologies.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor